Abstract:ObjectivesPulmonary arterial hypertension (PAH) is a severe complication of connective tissue disease (CTD) with a poor prognosis. There have been sporadic reports with respect to the clinical features and survival of CTD associated PAH (CPAH), however, those in Chinese with CPAH are unknown yet. The purpose of this study is to investigate the baseline characteristics, survival and risk factors of mortality in Chinese with CPAH.MethodsAll consecutive adult patients who visited the three medical centres with confirmed diagnosis of CPAH between July 2006 and May 2011 were enrolled into the study. For all these patients, PAH was confirmed by right heart catheterisation.ResultsA total of 144 patients (40.6±12.6 years old) were included in the study and 44% of them were associated with SLE. The other underlying CTDs, in the descending rank order, are pSS (15%), Takayasu arteritis (12%), MCTD (10%), SSc (8%) and some others (RA 3%, PM/DM 2%, adult onset Still9disease 2%, UCTD 2%, primary APS 1%, and ANCA associated vasculitis 1%). The median duration between symptom onset and diagnostic catheterisation was 16.5 months. At diagnosis, 57.6% of patients were in WHO functional class III/IV. The 6-min walk distance was 377.0±99.7 m. Mean pulmonary artery pressure was 49.7±14.4 mm Hg. Eighty-five percent of patients received vascular-targeted therapy. One hundred and twenty-nine patients were followed up with a median duration of 15.8 months (ranged 1.1–55.1 months). The survival rates of these patients at 1 and 3 years were 87.8% and 53.8%. The survival rates of patients with SLE associated PAH at 1 and 3 years were 90.0% and 57.1%. K-M survival analysis showed there were no significant differences in the survivals among different connective tissue diseases. Univariate Cox analysis showed shorter 6-min walk distance, lower cardiac output, cardiac index and mixed venous oxygen saturation, higher pulmonary vascular resistance (PVR), alkaline phosphatase (ALP), total bilirubin and direct bilirubin, lower total cholesterol and low-density lipoprotein were associated with high risk of death (all p<0.05). Multivariate Cox analysis showed higher PVR and ALP were independent predictors of mortality (HR were 1.32 (1.03–1.68) and 1.70 (1.01–2.87) respectively, both p<0.05). K-M analysis demonstrated the survival rate in PVR<15 wood unit group was higher significantly than that in ≥15 wood unit group (p=0.009), and the survival rate in ALp<150 U/l group higher than that in ≥150 U/l group (p=0.012).ConclusionsSLE was the most common underlying disease of CPAH in China; however, SSc-associated PAH was fewer in Chinese patients, which were much different from Caucasians. The survival of Chinese patients with CPAH at 1 and 3 years were 87.8% and 53.8%, which were similar with the data of Western countries. Furthermore, elevated PVR and ALP were independent risk factors of bad outcomes.

Serum High-Density Lipoprotein Cholesterol is Significantly Associated with the Presence and Severity of Pulmonary Arterial Hypertension: A Retrospective Cross-Sectional Study.

Association Between Non-High-density Lipoprotein Cholesterol and Coronary Artery Disease in Patients with Acute Coronary Syndrome: a Single-Centre Retrospective Cross-Sectional Analysis

Study Of The Correlation Between Blood Lipid Levels And The Severity Of Coronary Atherosclerosis In A Chinese Population Sample

Plasma Levels of High Density Lipoprotein Cholesterol and Outcomes in Chronic Thromboembolic Pulmonary Hypertension.

Differential serum lipid distribution in IPAH and CHD-PAH patients

Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)

The Correlation between Serum Phospholipid Fatty Acids and Blood Lipids in Hypertension

[Association of High-Density Lipoprotein Cholesterol with Risk of Cardiovascular Disease Mortality].

Association Between Serum C-Peptide As A Risk Factor For Cardiovascular Disease And High-Density Lipoprotein Cholesterol Levels In Nondiabetic Individuals

The differential diagnostic value of serum homocysteine for white coat hypertension.

Clinical significance of HIF-1α, ET-1, and NO as biomarkers in chronic obstructive pulmonary disease patients with pulmonary hypertension

Study of hypo-high-density-lipoproteinemia and coronary artery lesions in patients with coronary heart disease

Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China

Correlation between hs-CRP, IL-6, IL-10, ET-1, and Chronic Obstructive Pulmonary Disease Combined with Pulmonary Hypertension

Utility of serum uric acid levels in excluding pulmonary hypertension in severe chronic lung disease: insights from a tertiary care center

Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes

Baseline Characteristics And Survival Of Chinese Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

Correlation of Lipid Ratios with the Severity of Pulmonary Alveolar Proteinosis: A Cross-Sectional Study.

Association between high-density lipoprotein cholesterol and renal function in elderly hypertension: a cross-sectional study in Chinese population.

Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis

Increased serum PCSK9 in patients with idiopathic pulmonary arterial hypertension: insights from inflammatory cytokines